These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10150493)

  • 1. CFCs, their replacements, and the ozone layer.
    Noakes TJ
    J Aerosol Med; 1995; 8 Suppl 1():S3-7. PubMed ID: 10150493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ozone layer and metered dose inhalers.
    Boulet LP
    Can Respir J; 1998; 5(3):176-9. PubMed ID: 9707462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of environmentally acceptable fluorocarbons.
    Rusch GM
    Crit Rev Toxicol; 2018 Sep; 48(8):615-665. PubMed ID: 30474464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratospheric ozone, global warming, and the principle of unintended consequences--an ongoing science and policy success story.
    Andersen SO; Halberstadt ML; Borgford-Parnell N
    J Air Waste Manag Assoc; 2013 Jun; 63(6):607-47. PubMed ID: 23858990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFCS and the ozone layer.
    Hayman GD
    Br J Clin Pract Suppl; 1997 May; 89():2-9. PubMed ID: 9519506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in metered dose inhaler propellants].
    Chinet T
    Rev Mal Respir; 2000 Feb; 17(1):15-20. PubMed ID: 10756552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorofluorocarbon-free aerosol therapy in patients with pulmonary airflow obstruction.
    Matthys H
    Respiration; 1996; 63(6):321-4. PubMed ID: 8933648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Montreal Protocol and essential use exemptions.
    D'Souza S
    J Aerosol Med; 1995; 8 Suppl 1():S13-7. PubMed ID: 10150490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The president speaks: prevention is best: lessons from protecting the ozone layer.
    Woodcock A
    Thorax; 2012 Dec; 67(12):1028-31. PubMed ID: 23019254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled respiratory medications and the use of chlorofluorocarbons (CFCs). Thoracic Society of Australia and New Zealand.
    Pierce RJ; Seale JP; Ruffin RE
    Med J Aust; 1991 May; 154(10):701-4. PubMed ID: 2034155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New delivery systems and propellants.
    Dolovich M
    Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are chlorine-free compounds a solution for health problems caused by ozone-depleting substances?
    Valić F; Beritić-Stahuljak D
    Acta Med Croatica; 1996; 50(2):61-3. PubMed ID: 8688600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ozone depletion and climate change: impacts on UV radiation.
    McKenzie RL; Aucamp PJ; Bais AF; Björn LO; Ilyas M; Madronich S
    Photochem Photobiol Sci; 2011 Feb; 10(2):182-98. PubMed ID: 21253660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation on the environmental consequences of residual CFCs from obsolete household refrigerators in China.
    Zhao X; Duan H; Li J
    Waste Manag; 2011 Mar; 31(3):555-60. PubMed ID: 21093246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing an in vitro understanding of patient experience with hydrofluoroalkane-metered dose inhalers.
    Doub WH; Shah V; Limb S; Guo C; Liu X; Ngo D
    J Pharm Sci; 2014 Nov; 103(11):3648-3656. PubMed ID: 25228114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol.
    DeCanio SJ; Norman CS
    J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorofluorocarbon-free inhalers: are we ready for the change?
    Partridge MR; Woodcock AA; Sheffer AL; Wanner A; Rubinfeld A
    Eur Respir J; 1998 May; 11(5):1006-8. PubMed ID: 9648947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.